Bone Graft Substitute Market Overview

The Bone grafting is a surgical procedure used to operate severely complicated bone fractures. Bone grafts are implantable materials used during a medical process to aid in bone formation, bone healing, and osseous reconstruction. In contrast to autogenous or allogenous bone, a bone substitute can be described as a synthetic, inorganic, or biologically organic combination that can fill bone defects instead.

The global bone graft substitute market share is mainly driven by the rising incidents of road injuries and joint disorders, the development of biocompatible synthetic bone grafts, and increased demand for dental bone graft procedures. However, several factors such as the high costs of surgery and risks and complications arising from bone graft procedures are restraining the growth of the market.

The growth of the bone graft substitutes market is guided by the factors such as increasing orthopedic problems, exponential geriatric population, and rising demand for reconstructive orthopedic treatments. The adoption of bone graft substitutes in the oral healthcare sector is another factor responsible for catalyzing the growth of the bone graft substitutes market through the assessment period.

Bone graft substitute Market Segmentation

The global bone graft substitute market has been divided based on product type and application.

  • By type, the global bone graft substitutes market is segmented into autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, and others.
  • By application, the bone graft substitutes market has been segmented into spinal fusion, joint reconstruction, long bone, dental, foot & ankle,

Bone graft substitute Market Geographical Analysis

By region, the global bone graft substitutes market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas accounted for the largest share of the global market in 2016. It is expected to retain a significant share of the market by the end of 2027 striking a CAGR of 6.1%. The growth is attributable to the technological advancements in health care, the presence of key players, etc. The developed healthcare sector of the U.S. is poised to be one of the primary revenue generators in the regional bone graft substitutes market.

Europe is the second largest market for bone graft substitutes. It is estimated to thrive at 6.76% CAGR owing to increasing awareness about bone graft substitutes and rising healthcare expenditure. Meanwhile, Asia Pacific is set to register a relatively higher CAGR of 6.85% during the forecast period. The presence of fast-developing economies such as China and India are immensely supporting the growth of the bone graft substitutes market in the region. The trend is likely to perpetuate over the next couple of years.

The Middle East & Africa is expected to exhibit steady growth due to the developments in the healthcare sector in Gulf nations. However, the poor socio-economic situation in African regions remains an impediment to the market growth.

Bone graft substitute Market Key Players

  • ACE Surgical Supply Company
  • BioHorizons (US)
  • Dentium (South Korea)
  • Dentsply Sirona (US)
  • Institut Straumann AG (Switzerland)
  • Medtronic (Ireland)
  • Stryker (US)
  • Zimmer Biomet (US)

among others are some key companies in the global Bone graft substitute Market that are listed by MRFR for market research.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071